Should I buy BNY Mellon (BNY) stock or is it too late?
⭐ The most reliable of them, either direction: Argus Research — 79% of its targets hit on this sector (124 calls tested). It aims for $180 (+28 %), call made on July 23, 2026, maturing on July 23, 2027 (83 d ago).
✅ Reasons to believe
- Median price target $168, i.e. +19% from the current price ($141).
- 6 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Reasonable valuation (P/E ~16) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 11 ratings, 5 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on BNY
Median target $168 (+19%) · 11 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in BNY Mellon now?
We won't decide for you. The facts: 55% of analysts rate it a buy, median target $168 (+19%). Weigh that against valuation (P/E ~16). This is not personalized advice.
Is it too late to invest in BNY Mellon?
Not according to analysts: the median target ($168) is still +19% above the current price ($141). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is BNY Mellon still worth investing in?
It depends on the gap between the price ($141) and its estimated value: analysts target $168 on median (+19%), with 55% buys. Cross-check with their real reliability on BNY and the cautions above. Information, not advice.
What's the main risk in buying BNY?
The consensus is not unanimous: of 11 ratings, 5 are neutral.
→ Go deeper: the full BNY Mellon profile (consensus, analyst reliability, price target, performance).